Cannabismarketcap

Compare CV Sciences (CVSI) With Other Cannabis Stocks

Head-to-head stock comparisons across price, valuation, financials, and growth metrics

Company

CV Sciences (CVSI)

Price

$0.0083

Change

-10.80%

Market Cap

$1.9M

Sector

CBD

CBD Sector Peers

All CBD cannabis companies sorted by market capitalization. Click any ticker to see a detailed head-to-head comparison.

TickerNamePriceChange %MCap
CWBHFCharlotte's Web Holdings$0.24-1.33%$64.6M
PCLOFPharmaCielo$0.04110.00%$7.5M
YCBDcbdMD Inc$0.37+0.27%$4.2M
OILFFNextleaf Solutions$0.01700.00%$2.9M
DHBUFDelivra Health Brands$0.0621-3.99%$2.0M
ELLXFElixinol Global$0.00230.00%$527.6K

Top Matchups by Market Cap

Companies closest to CV Sciences in market capitalization — the most meaningful head-to-head comparisons.

DHBUFCBD

Delivra Health Brands

MCap: $2.0M

$0.0621-3.99%
Compare
BUDZMSO

Weed Inc

MCap: $2.1M

$0.0138-5.31%
Compare
CANNMSO

Trees Corp

MCap: $2.1M

$0.0193-0.52%
Compare
AKANInternational

Akanda Corp

MCap: $2.1M

$1.07-1.83%
Compare
CLCFFLP

Christina Lake Cannabis

MCap: $2.3M

$0.0185+0.54%
Compare

Cross-Sector Comparisons

Top cannabis companies outside the CBD sector. Compare across different business models and market segments.

JAZZBiotech

Jazz Pharmaceuticals

MCap: $13.30B

$205.06-0.83%
Compare
SMGAncillary

Scotts Miracle-Gro

MCap: $3.46B

$59.66+0.51%
Compare
CURLFMSO

Curaleaf Holdings

MCap: $2.14B

$8.48-0.12%
Compare
TRLVMSO

Trulieve Cannabis

MCap: $2.08B

$10.62-0.47%
Compare
GTBIFMSO

Green Thumb Industries

MCap: $1.54B

$6.41+0.16%
Compare

Comparing CVSI in the Cannabis Market

CV Sciences (CVSI) is a CBD and hemp companytrading at $0.0083 per share with a market capitalization of $1.9M. Among its CBD peers, CVSI ranks #6 by market cap, with trailing twelve-month revenue of $12.7M and a gross margin of 49.1%. The stock has moved -10.80% in the current session, trading on the OTC exchange.

When comparing CVSI against other cannabis stocks, investors should consider key financial metrics including price-to-sales ratio (0.1x), revenue growth (-14.90% YoY), and balance sheet strength (cash of $266.0K vs. debt of $18.0K). The comparison tables above allow you to evaluate CV Sciences relative to 6 sector peers and leading companies across all cannabis sub-sectors, helping you identify which stocks offer better value, stronger growth, or more favorable risk profiles.

Frequently Asked Questions

How does CVSI compare to other CBD stocks?+
CV Sciences has a market cap of $1.9M, placing it among 7 companies in the CBD sector. Its price-to-sales ratio is 0.1x. Its gross margin is 49.1%. Use the table above to compare these metrics against every CBD peer.
What is CVSI's biggest competitor?+
By market capitalization, the closest comparable company is Delivra Health Brands (DHBUF) with a market cap of $2.0M. Click the compare link to view a full head-to-head analysis.
Is CVSI overvalued compared to its peers?+
CV Sciences trades at a P/S ratio of 0.1x. Compare this to sector peers in the table above to determine relative valuation. A lower P/S may indicate relative value, while a higher P/S may reflect growth expectations.
Which cannabis stock has better margins than CVSI?+
CV Sciences has a gross margin of 49.1%. Of its 2 sector peers with reported margins, 1 report higher gross margins. See the Sector Peers table for a full ranking.
Can I compare CVSI to stocks in other cannabis sectors?+
Yes. The Cross-Sector Comparisons section above features top companies from sectors outside CBD. You can click any company to see a full side-by-side comparison with CVSI covering price, valuation, financials, and growth metrics.

All CVSI Comparisons

Every available head-to-head comparison for CV Sciences.

Related Pages

Disclaimer: The comparison data on this page is for informational purposes only and does not constitute financial advice, investment recommendations, or an endorsement of any security. Cannabis stocks are highly volatile and subject to unique regulatory risks. Always conduct your own research and consult a licensed financial advisor before making investment decisions.Cannabismarketcap does not guarantee the accuracy or completeness of any data presented.